Literature DB >> 32754723

The Cancer Imaging Phenomics Toolkit (CaPTk): Technical Overview.

Sarthak Pati1, Ashish Singh1, Saima Rathore1,2, Aimilia Gastounioti1,2, Mark Bergman1, Phuc Ngo1,2, Sung Min Ha1,2, Dimitrios Bounias1, James Minock1, Grayson Murphy1, Hongming Li1,2, Amit Bhattarai1, Adam Wolf1, Patmaa Sridaran1, Ratheesh Kalarot1, Hamed Akbari1,2, Aristeidis Sotiras1,3, Siddhesh P Thakur1, Ragini Verma1,2, Russell T Shinohara1,4, Paul Yushkevich1,2,5, Yong Fan1,2, Despina Kontos1,2, Christos Davatzikos1,2, Spyridon Bakas1,2,6.   

Abstract

The purpose of this manuscript is to provide an overview of the technical specifications and architecture of the Cancer imaging Phenomics Toolkit (CaPTk www.cbica.upenn.edu/captk), a cross-platform, open-source, easy-to-use, and extensible software platform for analyzing 2D and 3D images, currently focusing on radiographic scans of brain, breast, and lung cancer. The primary aim of this platform is to enable swift and efficient translation of cutting-edge academic research into clinically useful tools relating to clinical quantification, analysis, predictive modeling, decision-making, and reporting workflow. CaPTk builds upon established open-source software toolkits, such as the Insight Toolkit (ITK) and OpenCV, to bring together advanced computational functionality. This functionality describes specialized, as well as general-purpose, image analysis algorithms developed during active multi-disciplinary collaborative research studies to address real clinical requirements. The target audience of CaPTk consists of both computational scientists and clinical experts. For the former it provides i) an efficient image viewer offering the ability of integrating new algorithms, and ii) a library of readily-available clinically-relevant algorithms, allowing batch-processing of multiple subjects. For the latter it facilitates the use of complex algorithms for clinically-relevant studies through a user-friendly interface, eliminating the prerequisite of a substantial computational background. CaPTk's long-term goal is to provide widely-used technology to make use of advanced quantitative imaging analytics in cancer prediction, diagnosis and prognosis, leading toward a better understanding of the biological mechanisms of cancer development.

Entities:  

Keywords:  Brain tumor; Breast cancer; CaPTk; Cancer; Deep learning; Glioblastoma; Glioma; ITCR; Imaging; Lung cancer; Phenomics; Radiogenomics; Radiomics; Radiophenotype; Segmentation; Toolkit

Year:  2020        PMID: 32754723      PMCID: PMC7402244          DOI: 10.1007/978-3-030-46643-5_38

Source DB:  PubMed          Journal:  Brainlesion


  27 in total

1.  Engineering and algorithm design for an image processing Api: a technical report on ITK--the Insight Toolkit.

Authors:  Terry S Yoo; Michael J Ackerman; William E Lorensen; Will Schroeder; Vikram Chalana; Stephen Aylward; Dimitris Metaxas; Ross Whitaker
Journal:  Stud Health Technol Inform       Date:  2002

2.  User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability.

Authors:  Paul A Yushkevich; Joseph Piven; Heather Cody Hazlett; Rachel Gimpel Smith; Sean Ho; James C Gee; Guido Gerig
Journal:  Neuroimage       Date:  2006-03-20       Impact factor: 6.556

3.  The Extensible Neuroimaging Archive Toolkit: an informatics platform for managing, exploring, and sharing neuroimaging data.

Authors:  Daniel S Marcus; Timothy R Olsen; Mohana Ramaratnam; Randy L Buckner
Journal:  Neuroinformatics       Date:  2007

4.  Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy.

Authors:  Hongming Li; Maya Galperin-Aizenberg; Daniel Pryma; Charles B Simone; Yong Fan
Journal:  Radiother Oncol       Date:  2018-07-04       Impact factor: 6.280

5.  Breast parenchymal patterns in processed versus raw digital mammograms: A large population study toward assessing differences in quantitative measures across image representations.

Authors:  Aimilia Gastounioti; Andrew Oustimov; Brad M Keller; Lauren Pantalone; Meng-Kang Hsieh; Emily F Conant; Despina Kontos
Journal:  Med Phys       Date:  2016-11       Impact factor: 4.071

6.  Segmentation of Gliomas in Pre-operative and Post-operative Multimodal Magnetic Resonance Imaging Volumes Based on a Hybrid Generative-Discriminative Framework.

Authors:  Ke Zeng; Spyridon Bakas; Aristeidis Sotiras; Hamed Akbari; Martin Rozycki; Saima Rathore; Sarthak Pati; Christos Davatzikos
Journal:  Brainlesion       Date:  2017-04-12

7.  GLISTR: glioma image segmentation and registration.

Authors:  Ali Gooya; Kilian M Pohl; Michel Bilello; Luigi Cirillo; George Biros; Elias R Melhem; Christos Davatzikos
Journal:  IEEE Trans Med Imaging       Date:  2012-08-13       Impact factor: 10.048

8.  Individualized Map of White Matter Pathways: Connectivity-Based Paradigm for Neurosurgical Planning.

Authors:  Birkan Tunç; Madhura Ingalhalikar; Drew Parker; Jérémy Lecoeur; Nickpreet Singh; Ronald L Wolf; Luke Macyszyn; Steven Brem; Ragini Verma
Journal:  Neurosurgery       Date:  2016-10       Impact factor: 4.654

9.  Computational Radiomics System to Decode the Radiographic Phenotype.

Authors:  Joost J M van Griethuysen; Andriy Fedorov; Chintan Parmar; Ahmed Hosny; Nicole Aucoin; Vivek Narayan; Regina G H Beets-Tan; Jean-Christophe Fillion-Robin; Steve Pieper; Hugo J W L Aerts
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

10.  Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma.

Authors:  Michel Bilello; Hamed Akbari; Xiao Da; Jared M Pisapia; Suyash Mohan; Ronald L Wolf; Donald M O'Rourke; Maria Martinez-Lage; Christos Davatzikos
Journal:  Neuroimage Clin       Date:  2016-03-12       Impact factor: 4.881

View more
  12 in total

1.  Differentiation of paediatric posterior fossa tumours by the multiregional and multiparametric MRI radiomics approach: a study on the selection of optimal multiple sequences and multiregions.

Authors:  Jie Dong; Suxiao Li; Lei Li; Shengxiang Liang; Bin Zhang; Yun Meng; Xiaofang Zhang; Yong Zhang; Shujun Zhao
Journal:  Br J Radiol       Date:  2021-11-19       Impact factor: 3.039

2.  Machine Learning Using Multiparametric Magnetic Resonance Imaging Radiomic Feature Analysis to Predict Ki-67 in World Health Organization Grade I Meningiomas.

Authors:  Omaditya Khanna; Anahita Fathi Kazerooni; Christopher J Farrell; Michael P Baldassari; Tyler D Alexander; Michael Karsy; Benjamin A Greenberger; Jose A Garcia; Chiharu Sako; James J Evans; Kevin D Judy; David W Andrews; Adam E Flanders; Ashwini D Sharan; Adam P Dicker; Wenyin Shi; Christos Davatzikos
Journal:  Neurosurgery       Date:  2021-10-13       Impact factor: 5.315

3.  Benchmarking Various Radiomic Toolkit Features While Applying the Image Biomarker Standardization Initiative toward Clinical Translation of Radiomic Analysis.

Authors:  Mingxi Lei; Bino Varghese; Darryl Hwang; Steven Cen; Xiaomeng Lei; Bhushan Desai; Afshin Azadikhah; Assad Oberai; Vinay Duddalwar
Journal:  J Digit Imaging       Date:  2021-09-20       Impact factor: 4.903

4.  Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma.

Authors:  Erik Toorens; Danni Tu; Anahita Fathi Kazerooni; Sanjay Saxena; Vishnu Bashyam; Hamed Akbari; Elizabeth Mamourian; Chiharu Sako; Costas Koumenis; Ioannis Verginadis; Ragini Verma; Russell T Shinohara; Arati S Desai; Robert A Lustig; Steven Brem; Suyash Mohan; Stephen J Bagley; Tapan Ganguly; Donald M O'Rourke; Spyridon Bakas; MacLean P Nasrallah; Christos Davatzikos
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

5.  Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features.

Authors:  Anousheh Sayah; Camelia Bencheqroun; Krithika Bhuvaneshwar; Anas Belouali; Spyridon Bakas; Chiharu Sako; Christos Davatzikos; Adil Alaoui; Subha Madhavan; Yuriy Gusev
Journal:  Sci Data       Date:  2022-06-14       Impact factor: 8.501

6.  Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics.

Authors:  Qian Li; Fei Dong; Biao Jiang; Minming Zhang
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

7.  Incorporating Robustness to Imaging Physics into Radiomic Feature Selection for Breast Cancer Risk Estimation.

Authors:  Raymond J Acciavatti; Eric A Cohen; Omid Haji Maghsoudi; Aimilia Gastounioti; Lauren Pantalone; Meng-Kang Hsieh; Emily F Conant; Christopher G Scott; Stacey J Winham; Karla Kerlikowske; Celine Vachon; Andrew D A Maidment; Despina Kontos
Journal:  Cancers (Basel)       Date:  2021-11-01       Impact factor: 6.639

8.  The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics.

Authors:  Spyridon Bakas; Chiharu Sako; Hamed Akbari; Michel Bilello; Aristeidis Sotiras; Gaurav Shukla; Jeffrey D Rudie; Natali Flores Santamaría; Anahita Fathi Kazerooni; Sarthak Pati; Saima Rathore; Elizabeth Mamourian; Sung Min Ha; William Parker; Jimit Doshi; Ujjwal Baid; Mark Bergman; Zev A Binder; Ragini Verma; Robert A Lustig; Arati S Desai; Stephen J Bagley; Zissimos Mourelatos; Jennifer Morrissette; Christopher D Watt; Steven Brem; Ronald L Wolf; Elias R Melhem; MacLean P Nasrallah; Suyash Mohan; Donald M O'Rourke; Christos Davatzikos
Journal:  Sci Data       Date:  2022-07-29       Impact factor: 8.501

Review 9.  Visualizing Glioma Infiltration by the Combination of Multimodality Imaging and Artificial Intelligence, a Systematic Review of the Literature.

Authors:  Sabrina Honoré d'Este; Michael Bachmann Nielsen; Adam Espe Hansen
Journal:  Diagnostics (Basel)       Date:  2021-03-25

10.  Accurate and Robust Alignment of Differently Stained Histologic Images Based on Greedy Diffeomorphic Registration.

Authors:  Ludovic Venet; Sarthak Pati; Michael D Feldman; MacLean P Nasrallah; Paul Yushkevich; Spyridon Bakas
Journal:  Appl Sci (Basel)       Date:  2021-02-21       Impact factor: 2.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.